Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Cancer|June 1, 1996
Primary tracheal non-Hodgkin's lymphoma. A case report and review of the literatureP Fidias, C Wright, N L Harris, et al.
Anti-Cancer Drugs|March 12, 2004
Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumorsR Rachamalla, S Malamud, M L Grossbard, et al.
Cancer Research|August 1, 1992
Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricinM L Grossbard, J M Lambert, V S Goldmacher, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 12, 2004
Pancreatic carcinoma with brain metastases: case report and literature reviewF G El Kamar, K Jindal, M L Grossbard, et al.
European Urology|January 1, 1997
Intracaval extension of germ cell carcinoma: diagnosis via endovascular biopsy and a review of the literatureP Fidias, C M Fan, F J McGovern, et al.
Leukemia & Lymphoma|October 21, 2005
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphomaJ M Vose, B K Link, M L Grossbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factorL E Spitler, M L Grossbard, M S Ernstoff, et al.
Cancer|January 28, 1999
Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatmentC Y Fung, M L Grossbard, R M Linggood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigensS P Treon, Y Shima, M L Grossbard, et al.
The Oncologist|December 18, 2001
Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancerP Kozuch, M L Grossbard, A Barzdins, et al.
Pageof 4